Evidence map›Paper›PMID 26159289›Full record

ArticleImmunobiology2015

Simultaneous deletion of NOD1 and NOD2 inhibits in vitro alloresponses but does not prevent allograft rejection.

Sashi G Kasimsetty, Andrew T Scheinok, Alana A Shigeoka, Dianne B McKay

Abstract read
In one paragraph

Article in Immunobiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sashi G KasimsettyDivision of Nephrology, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, United States.
Andrew T ScheinokDivision of Nephrology, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, United States.
Alana A ShigeokaDivision of Nephrology, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, United States.
Dianne B McKayDivision of Nephrology, Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, United States. Electronic address: d1mckay@ucsd.edu.
University of California, San Diego · US

Funding

The Role of Inflammation in Ischemic Organ InjuryR01DK075718 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCKAY, DIANNE B · 2008 to 2012
$2.1M
Role of Nlrp3 in Ischemic Organ InjuryR01DK091136 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCKAY, DIANNE B · 2011 to 2015
$1.8M
NIDDK NIH HHS 5R01DK091136NIDDK NIH HHS 7R01DK075718NIDDK NIH HHS R01 DK075718NIDDK NIH HHS R01 DK091136
6 · The paper itself

Abstract

Pattern recognition receptors (PRRs) play an important role in host anti-donor responses to transplanted tissue. A key trigger of the host alloresponse involves recognition of foreign antigen presented on activated antigen presenting cells by the host T cells. Emerging data suggest that PRR blockade can abrogate host anti-donor responses by interfering with activation of antigen presenting cells, particularly activation of dendritic cells. Our study asked whether blockade of a well-characterized family of intracellular PRRs, the NOD family, interfered with alloantigen recognition and allograft rejection. We found that deletion of either NOD1 or NOD2 in antigen presenting cells (APCs) had no effect on induction of T cell proliferation to alloantigen, but that simultaneous deletion of NOD1 and NOD2 significantly inhibited T cell responses. There was however no effect of the NOD deletion on skin graft rejection when NOD1×NOD2 skin was transplanted onto allogeneic hosts or when WT skin was transplanted onto NOD1×NOD2 deficient recipients. The conclusion of this study is that in vitro alloresponses are negatively impacted by the simultaneous deletion of NOD1 and NOD2, but that allograft rejection across a stringent allo barrier is not affected. Our results suggest that the NOD family members, NOD1 and NOD2, play a collaborative role in T cell activation by alloantigen and that their blockade in vitro can inhibit T cell responses.

Indexed as

Gene DeletionAllograftsAnimalsAntigen-Presenting CellsDendritic CellsGraft RejectionIsoantigensLymphocyte ActivationMiceNod1 Signaling Adaptor ProteinNod2 Signaling Adaptor ProteinSkin TransplantationT-LymphocytesToll-Like Receptor 4IsoantigensNod1 Signaling Adaptor ProteinNod2 Signaling Adaptor ProteinToll-Like Receptor 4Allograft rejectionAlloresponsesInnate immunityNOD1NOD2Pattern recognition receptors

Identifiers

PMID26159289
PMCPMC4558238
OpenAlexW764384272

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.